Literature DB >> 34626

Characterization of the molecular defect in infantile and adult acid alpha-glucosidase deficiency fibroblasts.

N G Beratis, G U LaBadie, K Hirschhorn.   

Abstract

Different clinical expressions of acid alpha-glucosidase deficiency have been described. The present study was undertaken to investigate the basic metabolic defect in the infantile and adult forms of the disease. Acid alpha-glucosidase (EC 3.2.1.20) was purified from normal and from adult acid alpha-glucosidase deficiency fibroblasts. The pH optimum; Michaelis constant; electrophoretic mobility in starch; thermal denaturation at pH 4.0 and 7.0; and inhibition by turanose, alpha-methylglucoside and trehalose were the same in purified enzyme from normal and mutant cells. Placental acid alpha-glucosidase was purified to, or near, homogeneity. Monospecific antibodies raised against the enzyme in each of three enzyme peaks obtained from the last purification step were found to cross-react with the enzyme of all three peaks, and with purified, normal fibroblast enzyme. Cross-reacting material (CRM) also was identified in fibroblast lysates from normal subjects and from both forms of acid alpha-glucosidase deficiency. The amount of CRM in the adult form appeared to be significantly less than in normal cells or cells from the infantile form. Enzyme activity was demonstrated in the immune complexes of the normal and adult acid alpha-glucosidase deficiency fibroblasts, but not of the infantile form. Competition for antibody binding sites was observed between normal and both types of mutant enzymes. The findings indicate that this case of infantile acid alpha-glucosidase deficiency is the result of a structural gene mutation which causes the synthesis of a catalytically inactive (CRM-positive) enzyme protein. It appears that in the adult form, the mutation causes a reduction in the amount of the enzyme protein present in the cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 34626      PMCID: PMC371892          DOI: 10.1172/JCI109247

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Disk electrophoresis of basic proteins and peptides on polyacrylamide gels.

Authors:  R A REISFELD; U J LEWIS; D E WILLIAMS
Journal:  Nature       Date:  1962-07-21       Impact factor: 49.962

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Glycogen storage disease of the heart. I. Report of 2 cases in siblings with chemical and pathologic studies.

Authors:  P A DI SANT'AGNESE; D H ANDERSEN; H H MASON; W A BAUMAN
Journal:  Pediatrics       Date:  1950-09       Impact factor: 7.124

4.  The molecular heterogeneity of purified human liver lysosomal alpha-glucosidase (acid alpha-glucosidase).

Authors:  A K Murray; B I Brown; D H Brown
Journal:  Arch Biochem Biophys       Date:  1978-01-30       Impact factor: 4.013

5.  Acid alpha-glucosidase: a new polymorphism in man demonstrable by 'affinity' electrophoresis.

Authors:  D M Swallow; G Corney; H Harris; R Hirschhorn
Journal:  Ann Hum Genet       Date:  1975-05       Impact factor: 1.670

6.  Physico-chemical and immunological properties of acid alpha-glucosidase from various human tissues in relation to glycogenosis type II (Pompe's disease).

Authors:  J F Koster; R G Slee; J M Van der Klei-Van Moorsel; P J Rietra; C J Lucas
Journal:  Clin Chim Acta       Date:  1976-04-01       Impact factor: 3.786

7.  Antibodies to papain. A selective fractionation according to inhibitory capacity.

Authors:  R Arnon; E Shapira
Journal:  Biochemistry       Date:  1967-12       Impact factor: 3.162

8.  Molecular studies on glycogen storage diseases.

Authors:  J C Dreyfus; D Proux; Y Alexandre
Journal:  Enzyme       Date:  1974

9.  Some properties of human liver acid alpha-glucosidase.

Authors:  J F Koster; R G Slee
Journal:  Biochim Biophys Acta       Date:  1977-05-12

10.  Biochemical, immunological, and cell genetic studies in glycogenosis type II.

Authors:  A J Reuser; J F Koster; A Hoogeveen; H Galjaard
Journal:  Am J Hum Genet       Date:  1978-03       Impact factor: 11.025

View more
  19 in total

1.  Acid maltase deficiency: a case study and review of the pathophysiological changes and proposed therapeutic measures.

Authors:  H Isaacs; N Savage; M Badenhorst; T Whistler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-09       Impact factor: 10.154

2.  Identification of a missense mutation in one allele of a patient with Pompe disease, and use of endonuclease digestion of PCR-amplified RNA to demonstrate lack of mRNA expression from the second allele.

Authors:  N Zhong; F Martiniuk; S Tzall; R Hirschhorn
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

3.  Extensive genetic heterogeneity in patients with acid alpha glucosidase deficiency as detected by abnormalities of DNA and mRNA.

Authors:  F Martiniuk; M Mehler; S Tzall; G Meredith; R Hirschhorn
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

Review 4.  Glycogen storage diseases in animals and their potential value as models of human disease.

Authors:  H C Walvoort
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

5.  Immunohistochemical demonstration of acid alpha-glucosidase in muscle in Pompe's disease.

Authors:  N Ninomiya; I Matsuda; S Fukuda; T Iwamasa; M Osame
Journal:  Histochem J       Date:  1983-06

6.  An isozyme of acid alpha-glucosidase with reduced catalytic activity for glycogen.

Authors:  N G Beratis; G U LaBadie; K Hirschhorn
Journal:  Am J Hum Genet       Date:  1980-03       Impact factor: 11.025

7.  Demonstration of acid maltase protein in Pompe disease by use of immunohistochemical and enzyme immunoassay methods.

Authors:  N Ninomiya; T Iwamasa; I Matsuda; I Nonaka
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

8.  Characterization of the porphobilinogen deaminase deficiency in acute intermittent porphyria. Immunologic evidence for heterogeneity of the genetic defect.

Authors:  P M Anderson; R M Reddy; K E Anderson; R J Desnick
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

9.  The conservative substitution Asp-645-->Glu in lysosomal alpha-glucosidase affects transport and phosphorylation of the enzyme in an adult patient with glycogen-storage disease type II.

Authors:  M M Hermans; E de Graaff; M A Kroos; H A Wisselaar; R Willemsen; B A Oostra; A J Reuser
Journal:  Biochem J       Date:  1993-02-01       Impact factor: 3.857

10.  Subcellular distribution of acid alpha-glucosidase in fibroblasts and of antigenically cross-reactive material in Pompe's disease fibroblasts.

Authors:  T Iwamasa; K Nashiro; T Ohshita; I Matsuda
Journal:  Histochem J       Date:  1986 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.